Brokerages Set Astrana Health, Inc. (NASDAQ:ASTH) PT at $65.17

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the nine research firms that are currently covering the firm, Marketbeat.com reports. Two analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $65.17.

Several brokerages recently commented on ASTH. Robert W. Baird increased their price target on Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a research report on Wednesday, November 13th. KeyCorp started coverage on Astrana Health in a report on Friday, October 11th. They issued a "sector weight" rating for the company. TD Cowen initiated coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a "buy" rating and a $66.00 price target on the stock. Macquarie upgraded shares of Astrana Health to a "hold" rating in a research note on Monday, December 16th. Finally, BTIG Research boosted their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday, October 3rd.

Institutional Trading of Astrana Health

Several hedge funds and other institutional investors have recently modified their holdings of the stock. GAMMA Investing LLC acquired a new stake in Astrana Health during the third quarter worth approximately $34,000. Nisa Investment Advisors LLC bought a new position in shares of Astrana Health during the third quarter worth approximately $35,000. KBC Group NV acquired a new stake in Astrana Health during the 3rd quarter worth approximately $70,000. Quarry LP bought a new stake in Astrana Health in the 3rd quarter valued at $77,000. Finally, Quest Partners LLC bought a new stake in Astrana Health in the 3rd quarter valued at $133,000. Institutional investors own 52.77% of the company's stock.

Astrana Health Stock Down 6.9 %

Shares of ASTH traded down $2.18 during mid-day trading on Friday, hitting $29.48. 364,837 shares of the company's stock were exchanged, compared to its average volume of 362,206. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. Astrana Health has a 52 week low of $29.35 and a 52 week high of $63.20. The company has a market cap of $1.66 billion, a PE ratio of 22.68, a P/E/G ratio of 1.80 and a beta of 1.20. The company has a 50-day simple moving average of $39.55 and a 200 day simple moving average of $47.00.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting analysts' consensus estimates of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same quarter last year, the firm earned $0.47 earnings per share. On average, research analysts forecast that Astrana Health will post 1.16 earnings per share for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.